Reaching Patients Through Immunology Innovation
argenx (argenx.com) scores 83 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 84th percentile of 10279 Healthcare brands.
argenx is a Belgian-Dutch biopharmaceutical company founded in 2008 and headquartered in Ghent, specializing in immunology. The company develops antibody-based medicines aimed at treating severe and rare autoimmune diseases. Leveraging proprietary antibody engineering platforms, argenx focuses on bridging scientific innovation with clinical impact for patients underserved by existing treatment options, working closely with healthcare professionals who treat these conditions.
| Brand Name | argenx |
|---|---|
| Domain | argenx.com |
| Industry | Healthcare |
| Founded | 2008 |
| Headquarters | Ghent |
| Main Competitors | UCB (89/100), Alexion Pharmaceuticals (87/100), Immunovant (76/100), Regeneron (92/100), Roche/Genentech (84/100), Sanofi (90/100) |
Moz Domain Authority 47/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #337,397 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
argenx has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Reaching Patients Through Immunology Innovation" (Meta description: 5 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, GitHub; no detected presence on YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is argenx?", Claude could identify the brand as of September 2026. argenx is a Belgian-Dutch biotechnology company focused on developing antibody-based therapies for severe autoimmune diseases. Its lead product, Vyvgart (efgartigimod), targets the neonatal Fc receptor (FcRn) and was approved for treating generalized myasthenia gravis, with the c Best known for Developing Vyvgart (efgartigimod), an FcRn-blocking therapy for myasthenia gravis and other autoimmune diseases.
When asked "Best brands similar to argenx?", Claude would recommend argenx as of September 2026. It's a leading and well-recognized player in the FcRn-targeting autoimmune therapy space, making it relevant when discussing innovative biotech companies in immunology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
argenx's main competitors in Healthcare: UCB (89/100), Alexion Pharmaceuticals (87/100), Immunovant (76/100), Regeneron (92/100), Roche/Genentech (84/100).
Sources: Brand Analyzer scan
argenx is a Belgian-Dutch biopharmaceutical company specializing in immunology. Founded in 2008 and headquartered in Ghent, Belgium, it focuses on developing antibody-based medicines for patients with severe autoimmune and rare immunological diseases.
Sources: argenx official site
argenx has moderate AI-search visibility, scoring 56/100 on Brand Analyzer's AI visibility composite (visibility 70, trust 33, recommendation 57). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: argenx official site
argenx was founded in 2008. argenx operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
argenx is headquartered in Ghent. argenx operates in the Healthcare category.
Sources: Wikidata
argenx develops and delivers innovative antibody-based medicines designed to transform the lives of patients with severe autoimmune diseases. It uses proprietary antibody engineering platforms and deep immunology expertise to create novel treatments for rare and severe autoimmune conditions.
Sources: argenx official site
argenx scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: argenx official site
argenx can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: argenx official site
argenx offers antibody-based medicines developed through its proprietary antibody engineering platforms, targeting severe and rare autoimmune and immunological diseases.
Sources: argenx official site
argenx's treatments are used by patients with severe autoimmune and rare immunological diseases, and its work involves collaboration with healthcare professionals who treat these patients.
Sources: argenx official site
argenx is known for its expertise in antibody engineering and its focus on developing innovative treatments for rare and severe autoimmune diseases, positioning itself as a global immunology-driven biotechnology company.
Sources: argenx official site
argenx scores 56/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
argenx has a limited AI-visibility profile at 56/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (70/100) and its weakest is trust (33/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #337,397 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify argenx from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to argenx: Archy (83/100), Aptar (83/100), Artera (83/100), ATCC (83/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.